Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03831776
Title Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis (BosuPeg)
Acronym BosuPeg
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Olavs Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE | NOR | FIN | DNK


No variant requirements are available.